Definitive Healthcare Corp (DH)vsMerck & Company Inc (MRK)
DH
Definitive Healthcare Corp
$0.96
-6.57%
HEALTHCARE · Cap: $108.62M
MRK
Merck & Company Inc
$113.56
+0.36%
HEALTHCARE · Cap: $277.02B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 27131% more annual revenue ($65.77B vs $241.52M). MRK leads profitability with a 13.6% profit margin vs -57.5%. MRK earns a higher WallStSmart Score of 53/100 (C-).
DH
Hold37
out of 100
Grade: F
MRK
Buy53
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+84.5%
Fair Value
$10.92
Current Price
$0.96
$9.96 discount
Margin of Safety
-15.7%
Fair Value
$97.76
Current Price
$113.56
$15.80 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Mega-cap, among the largest globally
Every $100 of equity generates 37 in profit
Strong operational efficiency at 38.1%
Generating 2.9B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -40.4% — below average capital efficiency
Revenue declined 1.2%
Premium valuation, high expectations priced in
4.9% revenue growth
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : DH
The strongest argument for DH centers on Price/Book.
Bull Case : MRK
The strongest argument for MRK centers on Market Cap, Return on Equity, Operating Margin.
Bear Case : DH
The primary concerns for DH are EPS Growth, Market Cap, Return on Equity.
Bear Case : MRK
The primary concerns for MRK are P/E Ratio, Revenue Growth, Piotroski F-Score.
Key Dynamics to Monitor
DH profiles as a turnaround stock while MRK is a value play — different risk/reward profiles.
DH carries more volatility with a beta of 1.34 — expect wider price swings.
MRK is growing revenue faster at 4.9% — sustainability is the question.
MRK generates stronger free cash flow (2.9B), providing more financial flexibility.
Bottom Line
MRK scores higher overall (53/100 vs 37/100). DH offers better value entry with a 84.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Definitive Healthcare Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Definitive Healthcare Corp (DH) is a premier provider of data and analytics solutions tailored for the healthcare sector, serving a wide array of clients including pharmaceutical firms, payers, and healthcare providers. By leveraging extensive datasets and real-time analytics, the company enhances operational performance and provides strategic insights that lead to improved patient outcomes. In an environment marked by increasing complexity and demand for healthcare analytics, Definitive Healthcare is strategically positioned to deliver innovative solutions that drive operational excellence and competitive advantage for its partners. With a commitment to enhancing healthcare delivery through data-driven insights, DH is at the forefront of transforming the healthcare landscape.
Visit Website →Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?